Survival impact of cervical metastasis in squamous cell carcinoma of hard palate  by Li, Quan et al.
Vol. 116 No. 1 July 2013Survival impact of cervical metastasis in squamous cell carcinoma
of hard palate
Quan Li, MD,a Di Wu, MD,b,c Wei-Wei Liu, MD, PhD,b,c Hao Li, MD, PhD,b,c Wei-Guo Liao, MD,a
Xin-Rui Zhang, MD,b,c Zhi-Min Liu, MD,b,c Zhu-Ming Guo, MD,b,c and Xue-Kui Liu, MD, PhDb,c
Afﬁliated Tumor Hospital, Guangzhou Medical College, Guangzhou, Guangdong, China; and Sun Yat-Sen University, Guangzhou, Guangdong,
China
Objective. Evaluate the impact of cervical metastasis on the survival of patients with squamous cell carcinoma (SCC) of the
hard palate.
Methods. 155 cases of SCC of the hard palate hospitalized in Cancer Center, Sun Yat-sen University, from 1964 to 2008 were
reviewed retrospectively.
Results. The 5-year DSS rates for Nþ and N0 patients were 21.54% and 47.36% (P ¼ .048). The 5-year DSS rates were
47.36%, 27.48%, 15.55% and 0 for N0-N3 lesions, respectively (P ¼ .041). Cervical metastasis was detected in 40% patients
for initial consultation. After therapy, those individuals who presented with clinically negative necks had a 9.03% rate of
cervical metastasis. Ultimately, 49.03% of patients manifested disease to the cervical lymph nodes.
Conclusion. The presence of cervical nodal disease in patients is associated with the decreased survival rates. SCC of the hard
palate should be treated aggressively, and elective neck dissection should be considered because of the high rate of cervical
metastasis. (Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:23-27)Squamous cell carcinoma, the most common malig-
nancy of the oral cavcity, has a predilection for re-
gional lymphatic metastasis. These tumors metastasize,
usually through the lymphatic system to cervical lymph
nodes in levels I and II.1,2 Several studies have been
done on the metastasis of squamous cell carcinoma of
the tongue and ﬂoor of mouth.3 Only a few studies have
been performed concerning metastasis of squamous cell
carcinoma of the hard palate.4-7 There is often a mixture
of sites with these studies including tumors of the soft
palate, alveolus and/or cheek. This mixture of tumor
sites makes the evaluation of the impact of cervical
metastasis on the survival of patients with squamous
cell carcinoma of the hard palate more difﬁcult and
those studies looking exclusively at squamous cell
carcinoma of the hard palate are usually small. But it is
striking that the incidence of cervical lymph node
metastasis from cancer of the hard palate is signiﬁcant.
Therefore, we report only patients with a cancer con-
ﬁned to the hard palate and only squamous cell carci-
noma in an effort to speciﬁcally evaluate the risk of
regional metastasis from the hard palate.Q. Li and D. Wu Contributed equally to this work.
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Patients
Between 1964 and 2008, 155 patients were treated at the
Cancer Center of the Sun Yat-Sen University, for squa-
mous cell carcinoma of the hard palate. All patients were
previously untreated. Initial examination included medical
history, physical examination with special emphasis on the
head and neck region, routine blood tests, chest X-ray, and
electrocardiogram. CT-scan and biopsy were not routinely
performed for all patients. Patients with tumors extending
to the hard palate from adjacent areas (e.g., tonsil, soft
palate, and retromolar trigone) were excluded.
Patients and tumor characteristics are shown in Table I.
Patients ranged in age from 23 to 90 years (median age:
56 years). Forty-seven (30.32%) patients were female and
108 (69.68%) patientsweremale. The female tomale ratio
was 1:2.30. Staging was performed according to the
criteria for oral cancer developed by the International
Union against Cancer (UICC, 2002).Treatment
Treatment details are summarized in Table II. Fifty
(32.26%) patients were treatedwith surgery alone (stage I:
6; stage II: 18; stage III: 5; stage IV: 21), and 47 (30.32%)Statement of Clinical Relevance
We report only patients with a cancer conﬁned to the
hard palate and only squamous cell carcinoma in an
effort to speciﬁcally evaluate the risk of regional
metastasis from the hard palate.
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Table I. Patient characteristics
Characteristics No. of patients (%)
Sex Male 108 (69.68)
Female 47 (30.32)
Age 50 years 53 (34.19)
>50 years 102 (65.81)
Tumor size 2.5 cm 48 (30.97)
>2.5 cm 107 (69.03)
Duration of symptoms prior
to diagnosis
0-6 109 (70.32)
7-12 25 (16.13)
>12 21 (13.55)
T-stage T1 33 (21.29)
T2 59 (38.06)
T3 10 (6.45)
T4 53 (34.19)
N-stage N0 93 (60)
N1 32 (20.65)
N2 29 (18.71)
N3 1 (0.65)
Clinical stage I 18 (11.61)
II 46 (29.68)
III 21 (13.55)
IV 70 (45.16)
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chemoradiation therapy (stage I: 4; stage II: 13; stage III:
7; stage IV: 23). Fifty-eight (37.42%) patients not re-
ceiving surgery included 2 patients presentingwith distant
metastasis, 20 with locally unresectable disease, and 36
patients refused surgery or were not considered an ac-
ceptable surgical candidate.
Of the 97 (62.58%) patients who were treated primary
by surgery, palatal tumor resection was performed in 14
patients, total maxillectomy in 8, partial maxillectomy in
55, and palatectomy in 20.
Of the 62 (40%) patients who were clinically node-
positive at presentation, neck dissections were per-
formed in 32 patients (modiﬁed radical neck dissection
in 23 patients, radical neck dissection in 5 patients and
elective neck dissection in 4 patients). Thirty patients
were treated with radiation or chemotherapy or concur-
rent chemoradiation. Elective neck dissection was per-
formed in 1 patient who was clinically node-negative at
presentation and was found to be pathologically N0.Table II. Treatment modality of squamous cell carcinoma o
Treatment Stage I Stage II
Surgery alone 6 18
Surgery þ RT 2 12
Surgery þ CRT 0 0
Surgery þ CT 2 1
CRT alone 1 2
Chemotherapy alone 0 1
Radiation alone 5 9
None 2 3
RT, radiotherapy; CT, chemotherapy; CRT, chemoradiation therapy.Observation of the regional lymphatics was used in the
92 patients, clinically staged as N0.
Radiotherapy was performed with photons from
60Co or a linear accelerator (6 MV) with or without
9-12 MeV electrons. The dose of radiation (DT) ran-
ged from 42 to 79 GY. Chemotherapy regimens in-
cluded cisplatin or BPF (cisplatin, bleomycin, and
5-ﬂuorouracil).Follow-up
Patients were followed up regularly, every month for
3 months, every 3-6 months for 2 years and with de-
creasing frequency in the subsequent period. Median
follow-up period was 22.03 months (range from 0 to
388.3 months). The follow-up rate was 96.77%, and data
from patients lost to follow-up were censored. Follow-up
evaluations were carried out with physical examination
and/or imaging studies, including computed tomography,
magnetic resonance imaging.Statistical analysis
All statistical analyses of the data were performed with
SPSS 13.0 computer software (SPSS Inc., Chicago, IL,
USA). Survival differences according to the presence or
absence of cervical nodal disease and N-stage were
determined with KaplaneMeier method and the log-rank
test. A P value <.05 was considered statistically signiﬁ-
cant. Disease-speciﬁc survival was deﬁned as the date of
discharge from hospital until the day of death or last
follow-up.RESULTS
Locoregional recurrence and metastatic patterns of
patients are shown in Table III. Among the 44 recur-
rences, 22 had a local recurrence, 10 had both local
and cervical lymph node recurrence (5 patients
with no metastases in the neck at presentation and
5 patients with metastases in the neck at presentation),
12 had cervical lymph node recurrence (9 patients
with no metastases in the neck at presentation and
3 patients with metastases in the neck at presentation).f the hard palate by stage
Stage III Stage IV No. of patients (%)
5 21 50 (32.26)
4 18 36 (23.23)
2 1 3 (1.94)
1 4 8 (5.16)
3 5 11 (7.10)
0 10 11 (7.10)
6 10 30 (19.35)
0 1 6 (3.87)
Fig. 1. Disease-speciﬁc survival curves of the cohort of 155
patients with squamous cell carcinoma of the hard palate
according to the presence or absence of cervical nodal disease.
Fig. 2. Disease-speciﬁc survival curves of the cohort of 155
patients with squamous cell carcinoma of the hard palate
according to nodal stage.
Table III. Locoregional recurrence and patterns of
metastasis of patients in relation to neck staging at
initial presentation
Disease progression
Total
(n ¼ 49)
Initial neck stage
N0
(n ¼ 30)
Nþ
(n ¼ 19)
Local recurrence 22 15 7
Recurrence in neck nodes 12 9 3
Local þ neck nodes
recurrence
10 5 5
Distant metastasis 5 1 4
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the median time to recurrence was 7.9 months (range,
0.67-322.93 months).
Fourteen of the 44 patients with recurrence received
surgery alone, 6 received surgery plus postoperativeTable IV. Maxillary gingival, alveolus and palate squamous
reports
Author
Anatomical
site
No. of
patients
Nodal
disease (%)
Simental et al, 20065 Maxillary alveolus 13 11.50
Hard palate 13
Mourouzis et al, 20108 Alveolus 8 23.50
Palate 7
Alveolus and palate 1
Gingivia 1
Montes et al, 20087 Alveolus 11 20
Hard palate 2
Tuberosity 1
Yorozu et al, 20019 Hard palate 17 26.30
OBS, observation; MRN, modiﬁed radical neck dissection; CH, chemotheraradiotherapy, 1 received surgery plus postoperative
chemotherapy, 11 received chemotherapy alone, 2
received radiotherapy alone, and 10 patients were given
palliative treatment.
Five (3.23%) patients had distant metastasis and the
median time to metastasis was 20.53 months. Four
patients had lung metastasis, 1 had liver metastasis.
All patients were given palliative treatment and all died
of disease at 18.73 months from recurrence (range,
1.57-45.3 months).
Cervical metastasis was detected in 40% (62 cases) of
those individuals with hard palate squamous cell carci-
noma presenting for initial consultation (stageT1:
45.45%; T2: 35.59%; T3: 50%; T4: 40%), as evidenced
by either clinical examination or radiographic ﬁndings
consistent with malignancy. On average, 9.03% (14
cases) of the patients with clinically and radiographicallycell carcinoma cervical metastasis: a synopsis of current
Management
of neck
Management of primary
tumor Recurrence
OBS: 20N0 Surgery 29.2% regional
SND: 3N0
SND: 3Nþ
OBS: 13N0 Surgery 11.8% regional
MRN: 2Nþ
CH þ RT: 1Nþ
RT: 1Nþ
MRN: 3Nþ Surgery 21.4% regional
SND: 3N0
OBS: 7N0
MRN: 1N0
MRN RT RT 15.8% regional
py; RT, radiotherapy; SND, selective neck dissection.
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develop cervical disease 11.83 months after therapy.
Ultimately, 49.03% (76 cases) of our patients manifested
disease to the cervical lymph nodes. Primary tumor 2 cm
or less in the greatest dimension in 21 patients, primary
tumor more than 2 cm but not more than 4 cm in the
greatest dimension in 38 patients, and primary tumor
more than 4 cm in 17 patients.
The presence of nodal disease signiﬁcantly impacted
mean (64.16 vs. 136.31 months), median (22.03 vs.
50.07 months), and 5-year disease-speciﬁc (21.54% vs.
47.36%) survival times when compared to N0 patients
(P ¼ .048). The KaplaneMeier disease-speciﬁc sur-
vival curves for patients with and without nodal disease
are shown in Figure 1. With regard to N-stage, the
5-year disease-speciﬁc survival rates were 47.36%,
27.48%, 15.55%, and 0 for N0-N3 lesions, respectively
(P ¼ .041). Figure 2 displays KaplaneMeier disease-
speciﬁc survival curves for these nodal stages.
A literature search returned 4 reports addressing the
cervical lymph node status of patients with maxillary
gingival, alveolus and palate squamous cell carcinoma.
The patients reported bySimental et al.,5Mourouzis et al.,8
and Montes et al.7 reported patients with squamous cell
carcinoma of the maxillary gingival, alveolus, and palate
treated primarily by surgery. Yorozu et al.9 reviewed
17 patients with the hard palate squamous cell carcinoma
with an N0 neck who received radiation treatment limited
to the primary tumor in an N0 neck. Table IV summarizes
the nodal status at presentation, clinical failure rates, and
therapeutic modalities for these 4 study groups.
DISCUSSION
In our experience, the presence of nodal disease signiﬁ-
cantly impactedmean (64.16 vs. 136.31months), median
(22.03 vs. 50.07 months), and 5-year disease-speciﬁc
(21.54% vs. 47.36%) survival times when compared to
N0 patients (P ¼ .048). The 5-year disease-speciﬁc
survival rates were 47.36%, 27.48%, 15.55%, and 0 for
N0-N3 lesions, respectively (P ¼ .041). Presence of
lymph node metastases is a high-malignancy index, with
a subsequently very negative prognosis and advanced
N-stage signiﬁcantly correlate with worse prognosis.
A high incidence of cervical metastasis (30%)
observed in the sites of tongue and ﬂoor of mouth cancer
has been well documented.2,10,11 There are little data
speciﬁcally reporting on cervical metastasis from squa-
mous cell carcinoma arising on the hard palate. We
found cervical metastasis from squamous cell carcinoma
of the hard palate in 40% (62/155) patients. This rate is
much higher than expected. A review of the current
literature shows that at initial presentation, maxillary
palatal, gingival, and alveolar squamous cell carcinomas
manifest clinically detectable cervical metastasis at
rates ranging from 11.5% to 26.3% (Table IV).5,7-9This variation may be due to: 1) those studies looking
exclusively at squamous cell carcinoma of the hard
palate are usually small; 2) the mixture of tumor sites
makes interpretation of results more difﬁcult; 3) our
study presented data concerning the proportion of the
cervical metastasis only in the site of hard palate.
As for regional metastasis, we report a 9.03% (14/
155) rate in patients who presented initially without
cervical metastasis and were followed up by observation
alone. The patient groups presented in Table IV had
a potential for occult cervical metastasis ranging from
11.8% to 29.2%. Considering the patients presenting
with cervical disease at presentation as well as regional
failures in all 5 study groups, we ﬁnd a cervical failure
rate as high as 50%. Our study and review of the liter-
ature demonstrate that the rate of cervical metastasis
from squamous cell carcinoma of the hard palate is
comparable to that of those of the oral tongue, mandib-
ular gingival, and ﬂoor of the mouth. Although squa-
mous cell carcinomas of the hard palate replicate the
high frequency of regional metastatic disease as the oral
tongue and ﬂoor of the mouth, optimal management of
the clinically negative neck in patients diagnosed with
hard palate squamous cell carcinoma remains less clear.
For squamous cell carcinomas of the tongue, mandibular
alveolus, and ﬂoor of the mouth in N0 patients, out-
comes are signiﬁcantly improved after primary surgical
resection with concomitant neck dissection12,13 based on
the evidence presented herein, elective neck dissection
may be offered to patients with squamous cell carcinoma
of the hard palate even in cases with a negative clinical
examination.CONCLUSION
The presence of cervical nodal disease in patients is
associated with the decreased survival rates. Advanced
N-stage signiﬁcantly correlated with the worse prognosis.
Squamous cell carcinoma of the hard palate should be
treated aggressively, and elective neck dissection should
be considered because of the high rate of cervical
metastasis.REFERENCES
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